Meeting with Günther Sidl (Member of the European Parliament)

13 Nov 2025 · General Exchange of Views

Meeting with Angelika Winzig (Member of the European Parliament, Rapporteur for opinion) and Boehringer Ingelheim

5 Nov 2025 · Meeting with representatives of Boehringer Ingelheim & Pharmig

Meeting with Sophia Kircher (Member of the European Parliament) and Boehringer Ingelheim

4 Nov 2025 · Chemicals Omnibus, EU-US relations

Meeting with Michael Hager (Cabinet of Commissioner Valdis Dombrovskis)

13 Oct 2025 · Competitiveness of the pharmaceutical industry; environmental & industrial compliance omnibus.

Meeting with Angelika Winzig (Member of the European Parliament, Rapporteur for opinion)

11 Sept 2025 · Meeting with representatives of Pharmig

Response to Proposal for a Regulation of the European Parliament and Council to foster biotechnology in Europe

11 Jun 2025

Meeting with Alexander Winterstein (Cabinet of Commissioner Magnus Brunner)

11 Jun 2025 · Competitiveness of the pharmaceutical industry in Europe, and in particular in Austria

Meeting with Alexander Bernhuber (Member of the European Parliament)

14 May 2025 · Kommunale Abwasserrichtlinie

Response to Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on the “Strategy for European Life Sciences”

17 Apr 2025

Meeting with Hubert Gambs (Deputy Director-General Internal Market, Industry, Entrepreneurship and SMEs)

9 Apr 2025 · PHARMIG requested the meeting to address issues concerning the pharmaceutical industry and its competitiveness.

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down good manufacturing practice for veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council

17 Feb 2025

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medicinal products for human use at Union level, as well as templates for those joint clinical assessments

29 Mar 2024

Meeting with Claudia Gamon (Member of the European Parliament)

20 Feb 2024 · Pharmapaket

Meeting with Angelika Winzig (Member of the European Parliament)

7 Dec 2023 · Austausch zu Pharma-Legislativpaket

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

8 Nov 2023

Response to Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

8 Nov 2023

Meeting with Angelika Winzig (Member of the European Parliament)

25 Oct 2023 · pharma legislation

Meeting with Tiemo Wölken (Member of the European Parliament, Rapporteur) and 9 other interest representatives

7 Sept 2023 · Revision of the Pharmaceutical Legislation (staff level)

Meeting with Angelika Winzig (Member of the European Parliament)

7 Sept 2023 · EU Pharma Legislation

Meeting with Angelika Winzig (Member of the European Parliament)

20 Jul 2023 · Austausch zum Medizinprodukte Paket

Response to Council Recommendation on vaccine-preventable cancers

31 Jan 2023

Meeting with Günther Sidl (Member of the European Parliament) and 2 other interest representatives

20 Oct 2022 · General Exchange of Views

Meeting with Johannes Hahn (Commissioner) and 2 other attendees

28 Jul 2022 · Current economic and geopolitical challenges. European strategic autonomy. Consequences of Covid-19 for European health policy.

Response to Enhancing the coherence and effectiveness of compulsory licensing of patents in the EU, especially in crisis situations, including for export purposes to third countries

29 Apr 2022

Response to Proposal for a Regulation amending Regulations (EC) No 469/2009 and 1610/96 concerning supplementary protection certificates (SPCs) with a view to creating a unified granting procedure, and proposal for a Regulation creating a unitary SPC

5 Apr 2022

Response to Revision of Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC)

21 Feb 2022

Response to Evaluation and Revision of Regulation (EC) No 726/2004 and Directive 2001/83/EC

27 Apr 2021

Response to Proposal for an EP and Council Regulation on orphan and paediatric medicinal products

23 Dec 2020

Response to Commission Communication on a Pharmaceutical Strategy- Ensuring sustainable innovation and the availability and affordability of medicines and medical technologies for citizens

7 Jul 2020